AUROPODOX 200 mg tablets

Cefpodoxime proxetil 200 mg (equivalent to cefpodoxime 200 mg)

Class: Third-generation cephalosporin antibiotic (beta-lactam)

Manufacturer: Aurobindo Pharma Limited, India

Dosage Form: Film-coated or uncoated oral tablets

Similar Brands:

Uses:

Treatment of mild to moderate bacterial infections caused by susceptible organisms, including:

  • Respiratory tract infections: Acute bacterial sinusitis, acute exacerbations of chronic bronchitis, community-acquired pneumonia.
  • Pharyngitis/tonsillitis (e.g., Streptococcus pyogenes).
  • Skin and soft tissue infections (uncomplicated).
  • Urinary tract infections (uncomplicated, e.g., cystitis).
  • Acute otitis media (in some guidelines).
  • Gonorrhea (uncomplicated, single dose in some regimens).
    Not for viral infections (e.g., common cold/flu), fungal, or non-susceptible bacteria. Use only when bacterial etiology is suspected/confirmed; culture testing recommended for severe cases.

Dosage:

Oral, every 12 hours (BID), with food. Duration varies by infection (complete full course to prevent resistance/recurrence). Typical adult/adolescent dosing:

  • Pharyngitis/tonsillitis: 100 mg every 12 hours for 5–10 days.
  • Acute sinusitis, bronchitis exacerbations: 200 mg every 12 hours for 10 days.
  • Community-acquired pneumonia: 200 mg every 12 hours for 14 days.
  • Skin/soft tissue infections: 400 mg every 12 hours for 7–14 days.
  • Uncomplicated UTI: 100 mg every 12 hours for 7 days.
  • Uncomplicated gonorrhea: 200 mg single dose (often with other agents per guidelines).
    Children (if using adult tablets; often suspension preferred): Weight-based (e.g., 5 mg/kg every 12 hours; max adult dose).
    Renal impairment: Adjust interval (e.g., every 24 hours if CrCl <30 mL/min). Hepatic impairment: No major adjustment. Elderly: No routine change but monitor.

Side Effects:

Common (>1–10%): Diarrhea (most frequent), nausea, vomiting, abdominal pain, headache.
Less common: Rash, pruritus, vaginitis (in females), altered taste, superinfection (e.g., oral thrush/C. difficile).
Serious (rare, seek immediate care): Severe allergic reactions (anaphylaxis—hives, swelling, breathing difficulty), severe diarrhea (C. difficile colitis—watery/bloody, even months later), seizures (high doses/renal failure), Stevens-Johnson syndrome/toxic epidermal necrolysis (severe rash/blistering), liver enzyme elevations/hepatotoxicity, blood disorders (e.g., thrombocytopenia).

Warnings & Precautions:

Hypersensitivity: Contraindicated in cephalosporin/penicillin allergy (cross-reactivity ~5–10%).
Clostridium difficile-associated diarrhea: Monitor for persistent/severe diarrhea.
Renal impairment: Dose adjustment needed.
Superinfection: Possible with prolonged use (e.g., fungal).
Not for viral infections—avoid unnecessary use to prevent resistance.
Culture/susceptibility testing recommended before starting in serious infections.
Take with food; avoid antacids/H2 blockers/PPI if possible (may reduce absorption).

Pregnancy & Lactation:

  • Pregnancy: Limited human data; animal studies show no major risks at therapeutic doses—use only if clearly needed (former Category B equivalent); consult doctor.
  • Lactation: Excreted in low amounts in breast milk; generally compatible—monitor infant for diarrhea/thrush/rash; consult provider.

Drug Interactions:

Probenecid: Increases cefpodoxime levels (may require adjustment).
Antacids, H2 blockers, PPIs: Reduce absorption—separate dosing or take with food.
Oral contraceptives: Possible reduced efficacy (use backup method).
Warfarin: Potential increased anticoagulation (monitor INR).
Nephrotoxic drugs (e.g., aminoglycosides): Additive renal risk (rare).

Contraindications:

Known hypersensitivity to cefpodoxime, other cephalosporins, or any component.
History of severe immediate hypersensitivity to penicillins (cross-reactivity risk).

Price: Ksh 904.4/-

Notes:

Pack of 10 tablets.